Your browser doesn't support javascript.
loading
Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.
Shimomura, Takuya; Sekiguchi, Mitsuhiro; Honda, Reisa; Yamazaki, Miki; Yokoyama, Masami; Uchiyama, Susumu.
Afiliação
  • Shimomura T; Department of Pharmaceutical Technology, Astellas Pharma Inc.
  • Sekiguchi M; Department of Pharmaceutical Technology, Astellas Pharma Inc.
  • Honda R; Faculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University.
  • Yamazaki M; Department of Pharmaceutical Technology, Astellas Pharma Inc.
  • Yokoyama M; Department of Pharmaceutical Technology, Astellas Pharma Inc.
  • Uchiyama S; Department of Biotechnology, Graduate School of Engineering, Osaka University.
Biol Pharm Bull ; 45(9): 1300-1305, 2022.
Article em En | MEDLINE | ID: mdl-36047198
Understanding a monoclonal antibody's (MAb) physicochemical properties early in drug discovery is important for determining developability. Viscosity is important because antibodies with high viscosity have limited administration routes. Predicting the viscosity of highly concentrated MAb solutions is therefore essential for assessing developability. Here, we measured the viscosity and diffusion interaction coefficient (kDiff) of 3 MAbs under 15 different formulation conditions (pH and salt) and evaluated correlations between parameters. We also used a computational approach to identify the key factors underlying differences in concentration-dependent curves for viscosity among the MAbs and formulation conditions. Results showed that viscosity increased exponentially at high concentrations, and that this concentration-dependency could be predicted from kDiff. Attempts to set viscosity criterion for use by subcutaneous (SC) and intramuscular (IM) administration suggested that solutions with kDiff greater than -20 mL/g may be candidates. Computational analysis suggested that the presence of a large negative charge in the complementarity determining region (CDR) is a major factor underlying the difference in concentration-dependency among the three MAbs under different formulation conditions. Because it is possible to predict the administration form of antibody solutions, determination of kDiff at the early discovery stage may be essential for effective antibody development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regiões Determinantes de Complementaridade / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regiões Determinantes de Complementaridade / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article